Targeting Inflammation and Regeneration: Scaffolds, Extracellular Vesicles, and Nanotechnologies as Cell-Free...

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Immunology

Background:

• Osteoarthritis (OA) impacts over 250 million globally, characterized by cartilage degradation and synovial inflammation, yet lacks a definitive cure.
• Current treatments do not halt OA progression, highlighting the need for disease-modifying osteoarthritis drugs (DMOADs).
• Simultaneously addressing cartilage loss and inflammation is crucial for developing effective DMOADs.

Purpose of the Study:

• To review advanced cell-free techniques for cartilage tissue regeneration.
• To explore the potential of these techniques in managing inflammation for OA treatment.
• To discuss how cell-free methods align with modern tissue engineering principles.

Main Methods:

• Review of current literature on cell-free strategies in cartilage regeneration.
• Analysis of scaffolds, extracellular vesicles, and nanocarriers for immunomodulatory effects.
• Discussion of the role of controlled inflammation in tissue remodeling.

Main Results:

• Cell-free techniques provide enhanced control over inflammation compared to cell-based approaches.
• Scaffolds, extracellular vesicles, and nanocarriers can suppress or modulate inflammation.
• These methods support the paradigm of controlled inflammatory responses for tissue regeneration.

Conclusions:

• Cell-free strategies represent a significant advancement in cartilage tissue engineering.
• Targeting inflammation alongside cartilage repair offers a viable path toward DMOADs.
• Controlled immunomodulation is key for successful OA regeneration and remodeling.